
POINT-COUNTERPOINT: JAK2 Inhibitors for Myeloproliferative Neoplasms: Do They Prolong Survival?
Author(s) -
Mark Fuerst
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000403392.09930.77
Subject(s) - counterpoint , medicine , myeloproliferative disorders , pathology , psychology , pedagogy